Novavax to File Vaccine in U.K. and U.S. in Q2, CEO Says
Mar.12 -- Novavax Inc. Chief Executive Officer Stan Erck says the company's Covid-19 vaccine has been effective against variants. He speaks with Bloomberg's Alix Steel on "Bloomberg Markets."
Видео Novavax to File Vaccine in U.K. and U.S. in Q2, CEO Says канала Bloomberg Markets and Finance
Видео Novavax to File Vaccine in U.K. and U.S. in Q2, CEO Says канала Bloomberg Markets and Finance
Показать
Комментарии отсутствуют
Информация о видео
12 марта 2021 г. 22:58:23
00:08:52
Другие видео канала
Novavax Vaccine in 'Good Shape' for Approval Filing: CEO
‘A big deal’: Toobin reacts to Amy Coney Barrett’s vaccine ruling
Why you can't compare Covid-19 vaccines
Coronavirus and the money behind vaccines | FT Film
Vaccine safety update
Fauci: 'Practically Pleading' With People to Get Vaccinated
Novavax vaccine is different because it is a protein based vaccine: Physician![[Full VOD] 비만, 당뇨로 고통받았던 세종대왕. 어의가 그를 위해 처방한 것은? (KBS_388회_2011.10.08 방송)](https://i.ytimg.com/vi/yBaU3mcviuc/default.jpg)
[Full VOD] 비만, 당뇨로 고통받았던 세종대왕. 어의가 그를 위해 처방한 것은? (KBS_388회_2011.10.08 방송)
Bill Gates Warns Of ‘Next Pandemic’ After COVID - And How To Stop It | MSNBC Summit Series
'Bloomberg Surveillance' Full Show (07/15/2021)
Novavax vaccine trial prepares for FDA approval | Reporter researches 4th vaccine option
Coronavirus Update 118: AstraZeneca DNA COVID 19 Vaccine Explained (vs. Pfizer / BioNTech, Moderna)
Low impact, beginner, fat burning, home cardio workout. ALL standing!
Wall Street Week - Full Show (07/02/2021)
US, delta 83%
Novavax CEO talks receiving $384 million in CEPI funding for coronavirus vaccine candidate
Fmr. FDA chief Dr. Gottlieb: Novavax Covid vaccine data looks promising
Bloomberg Green: Taking the Carbon Out of Travel
All under-40s to be offered alternative to AstraZeneca vaccine: Professor Jonathan Van-Tam gives ...
Placebo or real thing: 11Alive investigator talks about vaccine trial journey